Physician

Jonathan H Tsai, M.D.

According to 2025 Medicare claims, Jonathan Tsai, M.D. (NPI: 1851368286) practices ophthalmology in the Killeen-Temple, TX market, with the plurality of this provider's patient population coming from Bell, TX. This provider's primary affiliated billing organization is SCOTT & WHITE CLINIC (NPI: 1093779704; TIN: 742958277) and primary practice location at 76504-6728. Tsai is affiliated with the Baylor Scott & White Quality Alliance (ACO ID: A2542) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Tsai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 368 traditional Medicare patients, billed 899 HCPCS/CPT codes, and received $128,155 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 837 prescription claims across 439 beneficiaries totaling $11,405 in drug costs, led by Erythromycin (Erythromycin Base). DME data shows 15 claims. Open Payments data shows 1 records totaling $41. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $38,979 to $11,405. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	509	1,193	$186,886
2016	572	1,404	$186,908
2017	517	1,316	$208,979
2018	525	1,340	$212,338
2019	600	1,582	$268,443
2020	456	1,104	$167,833
2021	435	995	$145,841
2022	455	889	$130,561
2023	483	1,109	$150,067
2024	368	899	$128,155

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	353	1,027	$38,979
2016	371	1,037	$37,928
2017	346	1,015	$40,547
2018	439	1,118	$30,528
2019	449	1,129	$26,570
2020	383	906	$16,313
2021	377	816	$15,880
2022	413	859	$14,231
2023	429	931	$15,484
2024	439	837	$11,405

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	109	109	$6,456
2016	97	97	$5,206
2017	95	95	$4,969
2018	79	79	$4,573
2019	51	54	$2,863
2020	14	20	$1,145
2021	16	20	$1,278
2022	16	21	$1,133
2023	12	15	$686
2024	11	15	$801

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	80	80	$83
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	136	139	$60
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	65	67	$41
92081	Exam of visual field with limited testing	86	88	$11
92285	Photography of content of eyes	114	117	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erythromycin	Erythromycin Base	451	5,036	$5,467
Prednisolone Acetate	Prednisolone Acetate	126	2,748	$3,719
Ofloxacin	Ofloxacin	128	2,534	$1,267
Bacitracin-Polymyxin	Bacitracin/Polymyxin B Sulfate	11	136	$175
Cephalexin	Cephalexin	27	189	$170

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2624	Polishing/resurfacing of ocular prosthesis	N	11	15	$801

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$41	Alcon Vision LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jonathan H. Tsai, M.D.?

Tedicare shows public-source Medicare data for Jonathan H. Tsai, M.D. (NPI 1851368286), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jonathan H. Tsai, M.D. have ACO affiliation data?

Jonathan H. Tsai, M.D. is shown with ACO affiliation data for Baylor Scott & White Quality Alliance (MSSP, ACO ID A2542) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Jonathan H. Tsai, M.D.?

Jonathan H. Tsai, M.D. is linked to SCOTT & WHITE CLINIC (billing NPI 1093779704) in the available physician profile data.

Does Jonathan H. Tsai, M.D. have Open Payments data?

Jonathan H. Tsai, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.